Stifel lowered the firm’s price target on Amdocs (DOX) to $97 from $100 and keeps a Buy rating on the shares following an earnings report the firm views as “decidedly mixed.” The FY26 outlook was lower than expected, notes the firm, which is lowering its own estimates.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOX:
- Amdocs price target lowered to $97 from $100 at BofA
- Amdocs: Buy Rating Affirmed Amid Strong Backlog, Cloud Growth, and AI Opportunities
- Amdocs Reports Fiscal 2025 Earnings and Strategic Outlook
- Amdocs expands managed services agreement with Globe
- Amdocs signs pact with Vivo to modernize operations support systems